Fulgent Genetics (FLGT) Current Leases (2019 - 2026)

Fulgent Genetics (FLGT) has 8 years of Current Leases data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Current Leases rose 45.26% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 45.26% YoY) and the FY2025 annual result came in at $1.5 million, up 1.32% from the prior year.
• Current Leases rose to $1.9 million in Q1 2026 per FLGT's latest filing, from $1.5 million in the prior quarter.
• The five-year high for Current Leases was $6.1 million in Q4 2022, with the low at $1.2 million in Q2 2025.
• Average Current Leases over 5 years is $2.3 million, with a median of $1.5 million recorded in 2025.
• Year-over-year, Current Leases plunged 63.53% in 2024 and surged 45.26% in 2026.
• Fulgent Genetics' Current Leases stood at $6.1 million in 2022, then sank by 35.47% to $4.0 million in 2023, then sank by 63.53% to $1.4 million in 2024, then advanced by 1.32% to $1.5 million in 2025, then jumped by 32.15% to $1.9 million in 2026.
• Business Quant data shows FLGT's Current Leases at $1.9 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.